METHOD FOR SUPPRESSING ATYPICAL PNEUMONIA CORONAVIRUS

FIELD: medicine. ^ SUBSTANCE: method involves administering ultrasonic ozonide-containing drug aerosol inhalation as ozonized oil and water mixture. Ultrasonic inhalation is additionally applied to bronchopulmonary system using highly refined aerosol containing ozonized oil having ozonide-based pero...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SHATAEV A.I, SHKURO JU.V, ROT G.Z, KOSENOK V.K, PEDDER V.V, GAPONENKO G.E, TERESHCHENKO A.JU, PEDDER A.V, OBUKHOVA L.A, TEMEREV V.L, DUSHECHKINA M.A
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY ELECTROTHERAPY HUMAN NECESSITIES HYGIENE MAGNETOTHERAPY MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES RADIATION THERAPY ULTRASOUND THERAPY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine. ^ SUBSTANCE: method involves administering ultrasonic ozonide-containing drug aerosol inhalation as ozonized oil and water mixture. Ultrasonic inhalation is additionally applied to bronchopulmonary system using highly refined aerosol containing ozonized oil having ozonide-based peroxide number P=800-900 and aerosol particle diameter equal to 0.3-0.5 mcm, giving at least two sessions per day at pathologic process active phase stage. Bronchopulmonary system tissue edema being relieved, ultrasonic inhalation procedure is first applied using highly refined aerosol containing ozonized oil having 20% ozonized oil emulsion of oil-in-water type having peroxide number P=200 and aerosol particle diameter equal to 0.3-0.5 mcm, giving at least two sessions per day at infection regeneration stage until clinically proved patient recovery data being obtained. Next, ultrasonic inhalation procedure is applied using medium refined aerosol containing ozonized oil having peroxide number P=800-900 and aerosol particle diameter equal to 5.0-10.0 mcm, each inhalation procedure being at least 10 min long. ^ EFFECT: enhanced effectiveness of treatment. ^ 2 cl, 1 dwg